Health & Safety

August 10, 2012

Laboratory developed tests covered under TRICARE demonstration may help guide cancer treatment decisions

by TRICARE Public Affairs

Some TRICARE beneficiaries will soon be able to take advantage of new technologies aimed at helping patients and healthcare providers make more informed decisions regarding treatment options for surgery, chemotherapy or radiation therapy for some types of cancer.

On May 22, 2012, two laboratory developed tests were approved for coverage by TRICARE under a demonstration project: the BRACAnalysis BRCA1 and BRCA2 tests (Myriad Genetic Laboratories, Inc.), and also, the Oncotype DX Breast Cancer Assay (Genomic Health, Inc.).

BRACAnalysis testing assesses a woman’s risk of developing hereditary breast or ovarian cancers based on detection of mutations in their BRCA1 and BRCA2 genes. The Oncotype DX breast cancer assay is a test that examines a breast cancer patient’s tumor tissue at the molecular level; specifically, it is hoped that this information can help individualize the planning of the patient’s breast cancer treatment. The complete description of this demonstration project is available at www.gpo.gov/fdsys/pkg/FR-2011-12-27/html/2011-33066.htm.

The criteria for which of these tests will be covered by TRICARE are scheduled to be published in the TRICARE Operations Manual in August 2012. TRICARE providers will be prepared to accept patients under the demonstration project by September 30, 2012; however, coverage for the approved use of these tests is retroactive to May 22, 2012. Beneficiaries should speak with their primary health care professional or their regional contractor to determine their eligibility for having these tests performed as a TRICARE benefit. Find regional contractor contact information at www.tricare.mil/contactus.




All of this week's top headlines to your email every Friday.


 
 

 
earthquake

Don’t let some recent shaking get you rattled

Background image from California Institute of Technology’s Southern California Earthquake Data Center Earthquakes are nothing new to residents in SoCal, but the recommended safety measures can be. Like most of California,...
 
 

News Briefs April 11, 2014

31st TES fundraiser The 31st Test and Evaluation Squadron Booster Club will hold a car wash fundraiser at the Bowling Center 9 a.m.-4:30 p.m., April 18. Get your car clean and help support the 31st TES. Volunteer appreciation Brig. Gen. Michael T. Brewer, 412th Test Wing commander, cordially invites you to attend the Edwards Air...
 
 

AFPC has expanded voluntary FM program waiver authority

The Air Force Personnel Center has been granted expanded waiver authority to waive some active duty service commitments for Airmen interested in voluntary separation under the fiscal year 2014 force management program, AFPC officials announced April 3. For example, we now have the authority to waive aviation retention pay (which requires recoupment of the unserved...
 

 

Gaining Altitude – Growth Opportunities for the Week

Through our character – an opportunity to reflect on important issues in our community - There is an old saying: “Give someone a fish and you feed them for a day; teach someone to fish and you feed them for life.” The same is true in developing character. ¬†You can give a law or command...
 
 
afrc-x56c

X-56A testbed arrives at NASA Armstrong Flight Research Center

NASA photograph by Ken Ulbrich The diminutive X-56A Multi-Use Technology Testbed, mounted on a small trailer, is pulled away from its home for the past year, Hangar 4305 at Edwards’ North Base. The latest in a long series...
 
 

Air Force updates officer, enlisted voluntary force management eligibility lists*

Select Airmen in specific categories who were not formerly eligible for fiscal year 2014 force management voluntary separation are now being offered voluntary separation. These individuals will not be subject to involuntary programs in fiscal year 2014. Officers from 33 Air Force specialty codes by year group and enlisted Airmen from seven AFSCs by grade...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>